REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
 
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Is Six-membered Consisting Of One Nitrogen And Five Carbon Atoms > Polycyclo Ring System Having The Six-membered Hetero Ring As One Of The Cyclos > Tetracyclo Ring System Having The Six-membered Hetero Ring As One Of The Cyclos > Plural Hetero Atoms In The Tetracyclo Ring System (e.g., Acronycines, Etc.) Plural Hetero Atoms In The Tetracyclo Ring System (e.g., Acronycines, Etc.)Plural Hetero Atoms In The Tetracyclo Ring System (e.g., Acronycines, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/11/07 - 20070010544 - Abca1 elevating compounds The present invention provides compounds useful for increasing cellular ATP binding cassette transporter ABCA1 production in mammals, and to methods of using such compounds in the treatment of coronary artery diseases, dyslipidiemias and metabolic syndrome. The invention also relates to methods for the preparation of such compounds, and to pharmaceutical ... 10/05/06 - 20060223839 - 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5h-chromeno-[3,4-f]-quinolines as selective progesterone receptor modulator compounds The present invention is directed to compounds, pharmaceutical compositions and methods for modulating processes mediated by Progesterone Receptor. Also provided are methods of making such compounds and pharmaceutical compositions. ... 08/31/06 - 20060194827 - 5-cycloalkenyl 5h-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds The present invention relates to methods for modulating processes mediated by progesterone receptor using nonsteroidal compounds and compositions which may be high affinity, high specificity agonists, partial agonists (i.e., partial activators and/or tissue-specific activators) and/or antagonists for progesterone receptors. ... 06/08/06 - 20060122211 - Hiv integrase inhibitors, pharmaceutical compositions and methods for their use are described. The beta-carboline hydroxamic acid compounds and compositions containing those compounds may be used to inhibit or modulate the activity of HIV integrase enzyme and to treat HIV integrase-mediated diseases and conditions. ... 05/04/06 - 20060094741 - Remedies for neuropathic pain and model animals of neuropathic pain (wherein R1, R2, R3, R4, R5, R6, R7, R8, A, and B have the same definitions as those described in the specification), and an animal model produced by administering (+)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octohydro-trans-quinolino[2,3-g]isoquinoline. The present invention makes it possible to perform drug treatment for neuropathic pain. The therapeutic effect of a compound against ... 05/04/06 - 20060094740 - Polycyclic compounds as potent alpha2-adrenoceptor antagonists wherein X, Z, R1 to R10, R15, R16, m, n, r and t are as defined in claim 1, or a pharmaceutically acceptable salt or ester thereof, useful as an alpha-2 antagonist. The compounds of formula I can be used for the treatment of diseases or conditions where antagonists of ... 03/09/06 - 20060052410 - 6h-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents The invention further provides compositions including the compounds, methods for the use of the compounds, and methods of preparation of the compounds. ... 08/11/05 - 20050176749 - Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof its stereoisomers thereof, or a solvate thereof, or a pharmaceutically acceptable salt thereof, where Z is S, O or NH; and R, R1, R2 Ra, Rb, Rc, Rd, Z, A and B are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune ... 07/28/05 - 20050165040 - Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use are described. The beta-carboline hydroxamic acid compounds and compositions containing those compounds may be used to inhibit or modulate the activity of HIV integrase enzyme and to treat HIV integrase-mediated diseases and conditions. ... 07/07/05 - 20050148617 - Fused heterocyclic compounds Compounds, compositions and methods are provided that are useful in the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor. In particular, the compounds of the invention are useful in the treatment and/or prevention of eating disorders, obesity, anxiety disorders and mood disorders. ... ### FreshPatents.com Support - Terms & Conditions |